Indaptus Therapeutics, Inc.

INDP

Indaptus Therapeutics, Inc.

INDP

Insider Sentiment (TTM):

Last Purchase:2023-08-14Last Sale:2022-02-01Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:70,631Shares Outstanding:10,956,650Institutional Ownership Pct.:0.64%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	8	1	9	6	6	4	6	7	7	10	13	16
Prepaid Expense And Other Assets Current	0	1	1	1	0	1	1	0	0	1	1	1
Assets Current	-	2	9	6	6	5	7	8	7	10	14	17
Assets Noncurrent
Property Plant And Equipment Net	-	-	-	-	-	-	-	-	-	-	0	0
Operating Lease Right Of Use Asset	-	-	-	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	-	-	-	0	0	0	1	1	1	1	1	1
Assets Noncurrent	-	-	-	0	0	0	1	1	1	1	1	1
Assets	-	-	9	7	7	5	7	8	8	11	15	18
Liabilities And Stockhold…
Accounts Payable And Other Accrued Liabilities Cur…	1	1	6	2	2	3	3	2	2	1	3	2
Operating Lease Liability Current	-	-	-	0	0	0	0	0	0	0	0	0
Convertible Notes Payable Current	-	-	-	-	7	-	-	-	-	-	-	-
Liabilities Current	-	1	6	2	9	3	3	2	2	2	3	2
Liabilities Noncurrent
Operating Lease Liability Noncurrent	-	-	-	-	-	-	-	0	0	0	0	0
Liabilities Noncurrent	-	-	-	-	-	-	-	0	0	0	0	0
Stockholders Equity
Common Stock Value	1	1	0	0	0	0	0	0	0	0	0	0
Liabilities	-	-	-	-	-	-	3	2	2	2	3	2
Preferred Stock Value	-	-	0	-	-	-	-	-	-	-	-	-
Additional Paid In Capital	96	84	84	78	69	68	64	62	59	58	57	57
Retained Earnings Accumulated Deficit	-86	-84	-81	-73	-70	-65	-60	-56	-53	-49	-45	-41
Stockholders Equity	11	1	3	5	-2	3	4	6	6	9	12	15
Liabilities And Stockholders Equity	12	2	9	7	7	5	7	8	8	11	15	18
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	1,000	1,000	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	133	113	2	2	1	16	0	10	9	9	8	8
Shares Outstanding	133	113	2	2	17	16	0	10	9	9	8	8
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	-	-	-	0.01	-
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	-	-	-	5	-
Preferred Stock Shares Issued	0	0	1	0	0	0	0	-	-	-	0	-
Preferred Stock Shares Outstanding	0	0	1	0	0	0	0	-	-	-	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	130.19%	90.57%	-9.43%	-	-	-	-	-	-	-	-	-
2025	-19.10%	-6.59%	-38.51%	-60.86%	-61.26%	-61.85%	-13.49%	-5.19%	-23.88%	7.65%	-4.08%	86.73%
2024	14.49%	2.42%	-0.72%	-16.37%	-32.16%	-31.87%	-9.57%	-23.48%	-20.87%	-42.75%	-43.00%	-58.12%
2023	-	-	-	23.39%	5.24%	0.81%	-17.91%	-34.33%	-38.06%	22.00%	1.00%	18.50%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	-	2.34	1.51	2.88	0.75	1.90	1.95	3.42	3.88	6.70	5.05	7.12
Quick Ratio	-	1.61	1.38	2.61	0.72	1.49	1.71	3.31	3.79	6.34	4.82	6.75
Working Capital	-	1.25M	3.15M	4.20M	-2.10M	2.35M	3.22M	5.40M	5.56M	8.76M	11.22M	14.48M
Leverage & Debt
Debt to Equity	-	0.75	1.95	0.49	-5.09	0.93	0.86	0.37	0.32	0.17	0.24	0.16
Debt Ratio	-	0.43	0.66	0.33	1.24	0.48	0.46	0.27	0.24	0.15	0.19	0.14
Efficiency & Turnover
Asset Turnover TTM	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.13	-1.72	-21.58	-16.92	-29.50	-31.64	-44.96	-43.85	-51.61	-1.77	-1.84	-1.79
Free Cash Flow Per Share TTM	-0.11	-1.53	-15.34	-10.01	-17.27	-26.99	-36.88	-33.94	-41.79	-1.47	-1.60	-1.55
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-9.07%	19.75%	38.79%	13.25%	7.71%	5.15%	-2.60%	-1.21%	7.71%	-1.54%	7.68%	4.01%
EPS Growth (1Y)	-99.55%	-94.56%	-52.00%	-61.42%	-42.83%	1,683.25%	2,348.84%	2,343.40%	2,865.34%	-2.02%	5.90%	2.24%
Valuation Metrics
P/E TTM	-22.59	-1.06	-0.13	-0.17	-0.36	-0.49	-0.52	-0.79	-1.15	-35.35	-26.84	-42.98
P/B TTM	30.63	15.98	0.89	0.62	-3.62	2.74	2.00	1.96	2.94	56.57	34.28	42.26
Market Cap	348.39M	19.94M	2.81M	2.86M	6.05M	7.67M	7.88M	11.79M	18.11M	529.51M	414.00M	648.06M
Enterprise Value	340.84M	18.44M	-5.70M	-2.96M	6.40M	3.78M	2.09M	4.41M	10.81M	519.76M	400.64M	632.09M
Calculated Values
Free Cash Flow TTM	-12.73M	-16.79M	-14.82M	-9.98M	-9.93M	-13.43M	-12.32M	-11.53M	-12.75M	-12.38M	-13.41M	-13.01M
Net Debt	-7.55M	-1.50M	-8.51M	-5.83M	344.80K	-3.89M	-5.79M	-7.38M	-7.30M	-9.74M	-13.36M	-15.96M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-08-14Purchase

Owner: Anderson, Glen R.

Title: -

Shares: 23,934

Price/Share: $2.34

Value: $56,005.56

Shares Owned: 1,190,400

Relationship: TenPercentOwner

Ownership: Indirect

2022-12-01Purchase

Owner: Litchev, Boyan Vesselinov

Title: Chief Medical Officer

Shares: 500

Price/Share: $1.87

Value: $935.00

Shares Owned: 1,150

Relationship: Officer

Ownership: Direct

2022-11-21Purchase

Owner: Meckler, Jeffrey A

Title: CEO and Director

Shares: 9,600

Price/Share: $1.90

Value: $18,240.00

Shares Owned: 75,374

Relationship: Director,Officer

Ownership: Direct

2022-09-08Purchase

Owner: Meckler, Jeffrey A

Title: CEO and Director

Shares: 10,308

Price/Share: $2.80

Value: $28,862.40

Shares Owned: 65,374

Relationship: Director,Officer

Ownership: Direct

2022-09-07Purchase

Owner: Meckler, Jeffrey A

Title: CEO and Director

Shares: 8,632

Price/Share: $2.57

Value: $22,184.24

Shares Owned: 55,066

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-08-14	Anderson, Glen R.	TenPercentOwner	-	Indirect	Purchase	23,934	2.34	$56,005.56	1,190,400	4
2022-12-01	Litchev, Boyan Vesselinov	Officer	Chief Medical Officer	Direct	Purchase	500	1.87	$935.00	1,150	4
2022-11-21	Meckler, Jeffrey A	Director,Officer	CEO and Director	Direct	Purchase	9,600	1.90	$18,240.00	75,374	4
2022-09-08	Meckler, Jeffrey A	Director,Officer	CEO and Director	Direct	Purchase	10,308	2.80	$28,862.40	65,374	4
2022-09-07	Meckler, Jeffrey A	Director,Officer	CEO and Director	Direct	Purchase	8,632	2.57	$22,184.24	55,066	4
2022-09-07	Linscott, Walt Addison	Officer	Chief Business Officer	Direct	Purchase	150	2.62	$393.00	150	4
2022-06-06	Meckler, Jeffrey A	Director,Officer	CEO and Director	Direct	Purchase	19,727	2.63	$51,882.01	45,374	4
2022-02-01	Newman, Michael James	Director,Officer,TenPercentOwner	CSO and Director	Indirect	Sale	14,130	5.00	$70,650.00	1,368,356	4
2021-11-18	Meckler, Jeffrey A	Director,Officer	CEO and Director	Direct	Purchase	11,187	5.82	$65,108.34	25,647	4
2021-09-14	Meckler, Jeffrey A	Director,Officer	CEO and Director	Direct	Purchase	12,000	7.00	$84,000.00	14,460	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

0.64%

Inst. Shares: 70,631

Shares Outstanding: 10,956,650

2025-12-31

3.33%

Inst. Shares: 32,195

Shares Outstanding: 966,124

2025-09-30

0.10%

Inst. Shares: 1,044

Shares Outstanding: 997,038

2025-06-30

0.05%

Inst. Shares: 307

Shares Outstanding: 574,923

2025-03-31

126.64%

Inst. Shares: 630,404

Shares Outstanding: 497,794

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	70,631	10,956,650	0.64%
2025-12-31	32,195	966,124	3.33%
2025-09-30	1,044	997,038	0.10%
2025-06-30	307	574,923	0.05%
2025-03-31	630,404	497,794	126.64%
2024-12-31	638,409	334,133	191.06%
2024-09-30	605,020	339,659	178.13%
2024-06-30	599,915	305,140	196.60%
2024-03-31	547,476	8,442,364	6.48%
2023-12-31	572,869	8,401,047	6.82%
2023-09-30	546,153	8,401,047	6.50%
2023-06-30	562,961	8,401,047	6.70%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Indaptus Therapeutics, Inc. (INDP) — SEC Financial Statements & Analysis

Indaptus Therapeutics, Inc. (INDP) is a pharmaceutical preparations company, incorporated in DE. Indaptus Therapeutics, Inc. trades on Nasdaq as: INDP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Indaptus Therapeutics, Inc. reported a Debt-to-Equity ratio of 0.75x, a Price-to-Book (P/B) ratio of 30.63x (TTM), at a market cap of $348.39M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.75x
P/B TTM: 30.63x
Market Cap: $348.39M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Indaptus Therapeutics, Inc. in?

Indaptus Therapeutics, Inc. (INDP) operates in the Pharmaceutical Preparations industry.

What is INDP's market cap?

Indaptus Therapeutics, Inc. (INDP) has a market capitalization of $348.39M as of 2026-06-30.

What exchange does INDP trade on?

Indaptus Therapeutics, Inc. (INDP) trades on the Nasdaq.

Where is Indaptus Therapeutics, Inc. incorporated?

Indaptus Therapeutics, Inc. is incorporated in DE.